INTELLICHECK INC (IDN)

US45817G2012 - Common Stock

3.19  +0.01 (+0.31%)

After market: 2.87 -0.32 (-10.03%)

Fundamental Rating

4

Taking everything into account, IDN scores 4 out of 10 in our fundamental rating. IDN was compared to 276 industry peers in the Software industry. The financial health of IDN is average, but there are quite some concerns on its profitability. IDN is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year IDN has reported negative net income.
IDN had a negative operating cash flow in the past year.
In the past 5 years IDN always reported negative net income.
IDN had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -8.33%, IDN perfoms like the industry average, outperforming 51.09% of the companies in the same industry.
Looking at the Return On Equity, with a value of -11.48%, IDN is in line with its industry, outperforming 58.03% of the companies in the same industry.
Industry RankSector Rank
ROA -8.33%
ROE -11.48%
ROIC N/A
ROA(3y)-18.19%
ROA(5y)-16.59%
ROE(3y)-23.49%
ROE(5y)-20.67%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of IDN (92.68%) is better than 98.91% of its industry peers.
In the last couple of years the Gross Margin of IDN has remained more or less at the same level.
IDN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 92.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.27%
GM growth 5Y0.28%

6

2. Health

2.1 Basic Checks

IDN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IDN has been increased compared to 1 year ago.
The number of shares outstanding for IDN has been increased compared to 5 years ago.
IDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

IDN has an Altman-Z score of -1.30. This is a bad value and indicates that IDN is not financially healthy and even has some risk of bankruptcy.
IDN's Altman-Z score of -1.30 is on the low side compared to the rest of the industry. IDN is outperformed by 76.64% of its industry peers.
IDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.3
ROIC/WACCN/A
WACC10.05%

2.3 Liquidity

IDN has a Current Ratio of 2.20. This indicates that IDN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.20, IDN is in the better half of the industry, outperforming 64.23% of the companies in the same industry.
A Quick Ratio of 2.20 indicates that IDN has no problem at all paying its short term obligations.
IDN has a better Quick ratio (2.20) than 64.96% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.2

6

3. Growth

3.1 Past

IDN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.38%, which is quite impressive.
The Revenue has grown by 18.38% in the past year. This is quite good.
IDN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.67% yearly.
EPS 1Y (TTM)52.38%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q233.33%
Revenue 1Y (TTM)18.38%
Revenue growth 3Y20.74%
Revenue growth 5Y33.67%
Revenue growth Q2Q13.76%

3.2 Future

The Earnings Per Share is expected to grow by 70.56% on average over the next years. This is a very strong growth
IDN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.55% yearly.
EPS Next Y69.7%
EPS Next 2Y70.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.98%
Revenue Next 2Y15.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IDN. In the last year negative earnings were reported.
Also next year IDN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

IDN's earnings are expected to grow with 70.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y70.56%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

IDN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTELLICHECK INC

NASDAQ:IDN (4/26/2024, 7:00:02 PM)

After market: 2.87 -0.32 (-10.03%)

3.19

+0.01 (+0.31%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap61.89M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.33%
ROE -11.48%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 92.68%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.2
Quick Ratio 2.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)52.38%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y69.7%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)18.38%
Revenue growth 3Y20.74%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y